Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Tarsus Pharmaceuticals, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues25.857.00.00.00.9
            Revenue growth-54.7%  -100.0% 
Cost of goods sold88.50.00.00.01.4
Gross profit-62.757.00.00.0-0.4
            Gross margin-242.9%100.0%  -49.8%
Research and development 41.718.83.2 
General and administrative44.925.48.21.10.4
EBIT-63.5-12.2-27.0-4.3-1.8
            EBIT margin-245.9%-21.3%  -199.7%
Pre-tax income-62.1-13.8-26.8-4.70.0
Income taxes0.00.10.00.00.0
            Tax rate0.0%  0.0% 
Net income-62.1-13.8-26.8-4.70.0
            Net margin-240.5%-24.2%  0.0%
 
Diluted EPS($2.52)($0.67)($4.32)($1.98)$0.00
Shares outstanding (diluted)24.620.66.22.41,759.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy